Trials / Terminated
TerminatedNCT04815018
Shifts in the Respiratory Microbiome and Clinical Outcomes of SARS-CoV-2
A Longitudinal Observational Study Identifying Shifts in the Respiratory Microbiome and Clinical Outcomes of SARS-CoV-2 in Nursing Home Residents
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 185 (actual)
- Sponsor
- Pathnostics · Industry
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Accepted
Summary
This is a longitudinal, prospective observational study focusing on health-related outcomes relative to potential changes in the respiratory microbiome seen with weekly SARS-CoV-2 testing in nursing home residents.
Detailed description
This study targets the influence of SARS-CoV-2, and the presence of mixed/co-infections on the respiratory microbiome. Their interrelationship will be characterized in a prospective observational study design. The observed changes will be correlated to medical (FEV1, CXR/CT, mortality, morbidity, symptoms) and clinical laboratory parameters (hematology, coagulation, bacterial/viral detection). The study aims at the detection of significant changes in microbiome in the respiratory tract following incidence of SARS-CoV-2 infection. These alterations in the respiratory microbiome will be determined by shotgun metagenomic sequencing. Ultimately, this can provide a better understanding of how SARS-CoV-2 and the presence of other bacteria and viruses affect the composition of the respiratory microbiome and a description of the microbiological etiology of these respiratory tract infections.
Conditions
Timeline
- Start date
- 2020-10-07
- Primary completion
- 2021-05-30
- Completion
- 2021-05-30
- First posted
- 2021-03-24
- Last updated
- 2021-06-30
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04815018. Inclusion in this directory is not an endorsement.